Home/Filings/4/0000950170-25-038698
4//SEC Filing

Smeal Tod 4

Accession 0000950170-25-038698

CIK 0001213037other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:03 PM ET

Size

5.5 KB

Accession

0000950170-25-038698

Insider Transaction Report

Form 4
Period: 2025-03-11
Smeal Tod
Chief Scientific Officer
Transactions
  • Award

    Stock Options

    2025-03-11+332,621979,805 total
    Exercise: $3.58Exp: 2035-03-11Common Stock (332,621 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.

Documents

1 file

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1
  • filerCIK 0001904824

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:03 PM ET
Size
5.5 KB